Absolute Contraindications to Combined Oral Contraceptive Pills
Combined oral contraceptives are absolutely contraindicated (Category 4) in women with conditions that represent unacceptable health risks, including cardiovascular disease with vascular complications, active VTE, thrombogenic mutations, current breast cancer, migraine with aura, severe liver disease, and age ≥35 years with heavy smoking (≥15 cigarettes/day). 1
Category 4 (Absolute) Contraindications
The US Medical Eligibility Criteria defines Category 4 as conditions representing unacceptable health risk if COCs are used 2. These include:
Cardiovascular & Thrombotic Conditions
- Age ≥35 years AND smoking ≥15 cigarettes daily 1, 3
- Acute VTE or history of VTE with ≥1 risk factor for recurrence 1
- Known thrombogenic mutations (e.g., Factor V Leiden, prothrombin mutation) 1, 3
- Current or history of ischemic heart disease 1
- Current or history of stroke 1
- Multiple risk factors for atherosclerosis 1
- Valvular heart disease with complications (pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis) 1
- Major surgery with prolonged immobilization 1
- Severe hypertension (SBP ≥160 mmHg or DBP ≥100 mmHg) 1
- Vascular disease 1
Postpartum Period
- ≤21 days postpartum, regardless of breastfeeding status 1 - This reflects the extremely high VTE risk immediately after delivery
Neurological Conditions
- Migraine with aura at any age 1, 3 - The combination significantly increases ischemic stroke risk 4
- Multiple sclerosis with prolonged immobilization 1
Hepatic Conditions
- Acute or flare of viral hepatitis 1, 3
- Severe (decompensated) cirrhosis 1
- Hepatocellular adenoma 1
- Malignant liver tumor (hepatoma) 1
Endocrine Conditions
- Diabetes mellitus with nephropathy, retinopathy, neuropathy, other vascular disease, or duration ≥20 years 1
Malignancy
- Current breast cancer 1
Autoimmune Conditions
Transplantation
- Solid organ transplantation complicated by acute or chronic graft failure, rejection, or cardiac allograft vasculopathy 1
Cardiac Complications
- Peripartum cardiomyopathy with normal or impaired cardiac function for ≤6 months OR moderate/severely impaired cardiac function at any time 1, 2
Category 3 (Relative) Contraindications - Use Only If No Alternatives
While not absolute contraindications, Category 3 conditions mean COCs should usually NOT be recommended unless other methods are unavailable or unacceptable 2:
- Age ≥35 years AND smoking <15 cigarettes daily 1, 3
- Controlled hypertension (SBP 140-159 or DBP 90-99 mmHg) 1
- History of VTE with no risk factors for recurrence 1
- Breastfeeding 21-29 days postpartum 1
- Breastfeeding 30-42 days postpartum with other VTE risk factors 1
- Past breast cancer with no evidence of disease for 5 years 1
Critical Clinical Pitfalls
Blood pressure measurement is mandatory before prescribing COCs 1. The most common contraindication found in clinical practice is hypertension, affecting 5.6-9.8% of users 5.
Do NOT prescribe COCs to women with migraine with aura - this combination increases ischemic stroke risk substantially (OR 2.08-16.9) 4. However, migraine without aura is not an absolute contraindication.
Age matters significantly: Women ≥35 years have 2.33 times higher odds of having contraindications 6. The combination of age ≥35 years with any smoking creates unacceptable cardiovascular risk.
Obesity amplifies risk: Women with BMI ≥30 have 2.24 times higher odds of contraindications 5. Combined with other risk factors (hypertension, diabetes), this substantially increases VTE and arterial thrombosis risk.
Pre-Prescription Requirements
Before prescribing COCs, obtain 1:
- Comprehensive medical history focusing on cardiovascular, thrombotic, hepatic, and neurological conditions
- Blood pressure measurement (mandatory)
- Pregnancy assessment (urine test if indicated)
Pelvic examination, breast examination, cervical cancer screening, and STI screening are NOT required before COC initiation 1.
The US Medical Eligibility Criteria is available as a mobile application to facilitate clinical decision-making 1.